tiprankstipranks
Lifecore Biomedical (LFCR)
NASDAQ:LFCR

Lifecore Biomedical (LFCR) Financial Statements

100 Followers

Lifecore Biomedical Financial Overview

Lifecore Biomedical's market cap is currently ―. The company's EPS TTM is $-3.321; its P/E ratio is -1.97; Lifecore Biomedical is scheduled to report earnings on July 30, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
May 23Feb 23Feb 23Nov 22Aug 22
Income Statement-
Total Revenue$ -6.49M$ 27.60M$ 27.60M$ 38.80M$ 43.35M
Gross Profit$ 9.08M$ 5.98M$ 5.98M$ 7.11M$ 6.25M
EBIT$ -20.16M$ -9.57M$ -9.60M$ -8.23M$ -7.67M
EBITDA$ -17.27M-$ -11.73M$ -5.34M$ -3.31M
Net Income Common Stockholders$ -34.12M$ -40.26M$ -40.19M$ -12.45M$ -11.35M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 19.09M$ 2.95M$ 2.95M$ 6.83M$ 4.22M
Total Assets$ 253.54M$ 236.15M$ 236.15M$ 279.07M$ 285.80M
Total Debt$ 101.64M$ 114.96M$ 114.96M$ 160.97M$ 157.04M
Net Debt$ 82.55M$ 112.01M$ 112.01M$ 154.13M$ 152.81M
Total Liabilities$ 218.46M$ 163.44M$ 201.95M$ 204.91M$ 188.90M
Stockholders Equity$ -4.23M$ 34.21M$ 34.21M$ 74.17M$ 96.90M
Cash Flow-
Free Cash Flow$ 12.05M$ -29.49M-$ -6.20M$ -4.46M
Operating Cash Flow$ -272.00K$ -17.17M-$ -2.95M$ -1.53M
Investing Cash Flow$ -8.16M$ 3.35M-$ -3.25M$ 206.00K
Financing Cash Flow$ 24.57M$ 15.13M-$ 8.81M$ 3.91M
Currency in USD

Lifecore Biomedical Earnings and Revenue History

Lifecore Biomedical Debt to Assets

Lifecore Biomedical Cash Flow

Lifecore Biomedical Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis